strongly and specifically in a temperature-and dose-dependent manner to only sulfatide of all of the glycolipids and glycoproteins tested. The avidity and specificity of binding, as well as the ability to inhibit the interaction specifically, suggest that the receptors to which M. hominis binds, particularly in the human urogenital tract, from which it is frequently isolated, are primarily, if not solely, sulfated glycolipids.
The ability of an infectious organism to attach to particular host receptors is one of the first and essential steps for establishing colonization of a host. Many microbes use cell surface molecules, especially glycoconjugates of lipids and proteins, as their receptors. The resultant interactions between the microbial adhesins and their host receptors are often specific and avid (4) .
Mycoplasma hominis is a member of a genus that is composed of genetically diverse, wall-less prokaryotes, all of which are obligate parasites. M. hominis is transmitted sexually and is consequently a frequent isolate from the human genital tract. It is also an adventitious etiologic agent of postpartum fever, septicemia, abscesses, and septic arthritis (9) .
The high concentrations of sulfated glycolipids in the human endometrium (6) and in mammalian male germ cells (10) suggest an advantage for organisms that can use these glycolipids as receptors. Lingwood and coworkers recently found that M. hominis binds to 2 ,ug of sulfogalactoglycerolipid and sulfogalactosylceramide, or sulfatide, on thin-layer plates (7) . However, it was not demonstrated that this attachment is a specific adhesin-receptor interaction rather than some form of nonspecific, perhaps ionic, binding.
To better understand the ability of M. hominis to colonize and cause disease, we screened a variety of glycoconjugates for the ability to serve as receptors for M. hominis adherence. We also examined the specificity and avidity of M. hominis attachment to sulfatide.
All saccharides, polysaccharides, and glycoproteins were purchased from Sigma Chemical Company (St. Louis, Mo.), as were cholesterol, cholesterol sulfate, phosphatidylcholine, and bovine serum albumin (BSA). The glycolipids GM1, asialo-GM1, GD1a, GDib, GT1b, GM2, GM3, galactosylceramide, glucosylceramide, lactosylceramide, globoside, and sulfatide were also obtained from Sigma. Asialo-GM2, trihexosylceramide, and Forssman antigen were purchased from BioCarb Inc., Gaithersburg, Md.
M. hominis 1620 (passage level 3 to 5) was used predominantly in this study. Strain 1620 was originally isolated from the synovial tissue of a chronically infected septic arthritis patient (13 (12 to 17 Ci/mmol; Dupont-New England Nuclear) as previously described (2) . After harvesting and two washes in 0.05 M Tris-HCl (pH 7.6)-110 mM sodium chloride (TBS), the organisms were suspended in 10 ml of buffer, passed four times through a 23-gauge needle, and further diluted with buffer to approximately 108/ml. Depending on the experiment, this dilution provided approximately 106 cpm/ml.
Thin-layer chromatography (TLC) overlays were performed as a modification of the method described in reference 5. Briefly, glycolipids and lipids were separated on aluminum-backed silica gel high-performance plates (Merck, Darmstadt, Germany) with chloroform-methanol-water (60: 35:8). Following chromatography, the plates were blocked with 1% BSA in TBS (TBS-BSA) for 1 h. Plates were then incubated for 3 h at 370C with approximately 108 CFU of unlabeled M. hominis per ml in TBS-BSA. After 30 min of washing in TBS, the plates were incubated overnight at 40C with monoclonal antibodies (1:1,000 dilution) specific for surface-exposed, protease-sensitive, integral membrane proteins of M. hominis (11) . After another wash in TBS-BSA, the plates were incubated for 1 h at room temperature with "2I-labeled goat anti-mouse antibody. After a 2-h wash with TBS at 40C, the plates were dried and autoradiographed (2-to 4-h exposure time). Duplicate plates were stained with orcinol for reference.
The solid-phase binding assay was used to measure attachment and inhibition of attachment of M. hominis to purified glycolipids and glycoproteins immobilized in polystyrene microtiter plates and was performed essentially as described previously (5, 12) . Adhesion of M. hominis to WiDr cells grown on glass coverslips was performed as previously described (5) .
The glycolipids listed in Table 1 as substrates for attachment. M. hominis was found to bind only to sulfatide among the glycolipids tested (300 to > 15,000 cpm); it did not attach to any of the glycoproteins in this study (background counts of <80 cpm). As was observed with the TLC overlays, binding of M. hominis to wells containing various concentrations of immobilized sulfatide was dose dependent; the prokaryote bound to wells containing as little as 0.125 pg per well (Fig. 2) . Temperature dependence was also observed, with maximal binding at 370C.
We measured the abilities of various saccharides and polysaccharides to inhibit attachment of M. hominis 1620 to immobilized sulfatide (Table 2) . Dextran sulfate (DS), a multibranched, sulfated polymer of glucose with a molecular weight (MW) of 500,000 (high-MW DS) exerted the most inhibition of M. hominis attachment: at 1.8 ± 1.0 pLg/ml, high-MW DS inhibited attachment ofM. hominis to 1 ,ug of sulfatide by 50%. Fucoidan, a sulfated polymer of fucose, also inhibited attachment to 1 ,ug of sulfatide per well, although 50% inhibition was attained at a concentration of 26 + 13.1 pg of fucose per well. DS with an MW of 5,000 (low-MW DS) was not as effective an inhibitor of M. hominis binding to sulfatide as either high-MW DS or fucoidan, in that 50% inhibition was not observed, even at concentrations of 200 ,ug/ml (Fig. 3 ).
Sodium sulfate was tested as an inhibitor to determine whether the observed adhesion of M. hominis to sulfatide could be a trivial ionic interaction. No inhibition from the salt, even at 10-2 M in the presence or absence of high-MW dextran (to mimic possible sequestration of charges by DS), was observed. Other sulfated polymers, including heparin, heparan sulfate, and chondroitan sulfates, exerted no M. hominis H5488, isolated from the blood of a septicemia patient, was used instead of strain 1620 (data not shown).
In contrast, reference laboratory strain M. hominis PG21 has been reported to attach less well than patient isolates to cell culture substrates (3). We found not only that laboratory strain PG21 bound less well to WiDr cells than did patient isolate strains 1620 and H5488 (Fig. 4A and B) but also that its attachment was inhibited less than 50% by high-MW DS (Fig. 4B) . In contrast, 100 ,ug of low-MW DS per ml was able to inhibit approximately 75% of strain PG21 binding to WiDr cells. In common with the patient isolates of M. hominis, however, 100 pg of fucoidan per ml inhibited 80% of PG21 attachment. The reference strain's comparative inability to adhere avidly to cell culture monolayers, as well as the inhibitory effects of low-MW DS, instead of high-MW DS, on its adherence, suggests that significant changes in the (8) , as does the related genital mollicutes Ureaplasma urealyticum (human origin) and U. diversum (bovine origin) (7) . The increasing body of evidence suggests that these sulfated glycolipids represent readily available and important receptors for the adherence of pathogens (4, 5) .
In summary, we investigated the attachment specificity of M. hominis to sulfatide and other compounds by using adherence assays to immobilized substrates and cell culture monolayers. We found that this mycoplasma of human origin binds to sulfatide only in TLC and in microtiter wells. The ability to inhibit its binding in these two systems also translates to an ability to inhibit binding to cell cultures. The attachment is avid, temperature dependent, and dose dependent. Furthermore, its binding to sulfatide or cells can be inhibited virtually completely by high-MW DS. These data demonstrate that attachment of M. hominis to sulfatide is not an ionic interaction between cells but rather a specific adhesin-receptor interaction. Given the preponderance of sulfated glycoconjugates in the human male and female genital tracts, as well as the lower concentrations of sulfated glycoconjugates expressed on cell surfaces in other tissues, the data suggest that the only cell surface receptors used by M. hominis for adherence in vivo could well be sulfatide or structurally related molecules.
